Document and Entity Information Document Information [Table] Document Information [Line Items] Document and Entity Information Document Type Document Quarterly Report Document Period End Date Document Transition Report Securities Act File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Condensed Consolidated Balance Sheets Statement [Table] Statement [Line Items] Statement Assets [Abstract] Assets Assets, Current [Abstract] Current assets Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Other Assets, Noncurrent Other assets Assets Total assets Liabilities and Equity [Abstract] Liabilities, Redeemable Noncontrolling Interest and Shareholders' Equity Liabilities, Current [Abstract] Current liabilities Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued expenses Total accounts payable and accrued expenses Liabilities, Current Total current liabilities Liabilities Total liabilities Commitments and Contingencies Commitments and contingencies (Note 9) Redeemable Noncontrolling Interest, Equity, Carrying Amount Redeemable noncontrolling interest Equity, Attributable to Parent [Abstract] Shareholders' Equity Preferred Stock, Value, Issued Preferred shares, $0.0001 par value, 1,000,000 shares authorized as of June 30, 2025 and December 31, 2024; no shares issued and outstanding as of June 30, 2025 and December 31, 2024 Common Stock, Value, Issued Class A Ordinary Shares, $0.0001 par value; 300,000,000 shares authorized as of June 30, 2025 and December 31, 2024; 62,064,270 and 65,297,530 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Equity, Attributable to Parent Total Zura Bio Limited shareholders' equity Equity, Attributable to Noncontrolling Interest Noncontrolling interest Noncontrolling interest balance Equity, Including Portion Attributable to Noncontrolling Interest Balance Balance Total shareholders' equity Liabilities and Equity Total liabilities, redeemable noncontrolling interest and shareholders' equity Preferred Stock, Par or Stated Value Per Share Preferred shares, par value per share (in dollars per share) Preferred Stock, Shares Authorized Preferred shares authorized (in shares) Preferred shares, shares authorized Preferred Stock, Shares Issued Preferred shares issued (in shares) Preferred Stock, Shares Outstanding Preferred shares outstanding (in shares) Common Stock, Par or Stated Value Per Share Class A ordinary shares, par value per share (in dollars per share) Common Stock, Shares Authorized Class A ordinary shares authorized (in shares) Common Stock, Shares, Issued Class A ordinary shares issued (in shares) Common Stock, Shares, Outstanding Ending Balance (in shares) Beginning Balance (in shares) Class A ordinary shares outstanding (in shares) Condensed Consolidated Statements of Operations Operating Expenses [Abstract] Operating expenses: Research and Development Expense Research and development General and Administrative Expense General and administrative Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Other Nonoperating Income (Expense) [Abstract] Other (income)/expense, net: Investment Income, Interest Interest income Fair Value Adjustment of Warrants Change in fair value of private placement warrants Loss(Gain) from the change in fair value of the private placement warrants Other Nonoperating Income (Expense) Other income, net Nonoperating Income (Expense) Total other income, net Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss before income taxes Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Net loss before redeemable noncontrolling interest Net loss Net loss Net loss Temporary Equity, Accretion to Redemption Value, Adjustment Accretion of redeemable noncontrolling interest to redemption value Accretion of redeemable noncontrolling interest to redemption value Value of adjustment from redemption value to carrying value of temporary equity during the period. Temporary Equity, Redemption Value To Carrying Value Adjustment Adjustment of redeemable noncontrolling interest from redemption value to carrying value Net Income (Loss) Available to Common Stockholders, Basic Net loss attributable to Class A Ordinary Shareholders of Zura Earnings Per Share, Basic Net loss per share attributable to Class A Ordinary Shareholders of Zura, basic (in dollars per share) Earnings Per Share, Diluted Net loss per share attributable to Class A Ordinary Shareholders of Zura, diluted (in dollars per share) Weighted Average Number of Shares Outstanding, Basic Weighted-average Class A Ordinary Shares used in computing net loss per share attributable to Class A Ordinary Shareholders of Zura, basic (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted-average Class A Ordinary Shares used in computing net loss per share attributable to Class A Ordinary Shareholders of Zura, diluted (in shares) Condensed Consolidated Statements of Changes in Redeemable Noncontrolling Interest and Shareholders' Equity Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Class A Ordinary Shares Additional Paid-in Capital [Member] Additional Paid-in Capital Retained Earnings [Member] Accumulated Deficit Noncontrolling Interest [Member] Noncontrolling interest Information by temporary equity.. Temporary Equity [Axis] The components of temporary equity. Temporary Equity [Domain] This member stands for redeemable noncontrolling Interest. Redeemable Noncontrolling Interest [Member] Redeemable Noncontrolling Interest Sale of Stock [Axis] Sale of Stock [Domain] Represents information pertaining to At The Market Offering. At The Market Offering [Member] At The Market Offering Represents information pertaining to Private Placement April 2024 PrivatePlacementApril2024 [Member] April 2024 Private Placement Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Represents the information pertaining to Pre-Funded Warrants. Pre-Funded Warrants [Member] Pre-Funded Warrants Represents the information pertaining to Private Placement Warrants. Private Placement Warrants [Member] Private placement warrants Private Placement Warrants Increase (Decrease) in Temporary Equity [Roll Forward] Redeemable Noncontrolling Interest Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests Balance Balance Value of adjustment from redemption value to carrying value of temporary equity during the period. Temporary Equity, Redemption Value To Carrying Value Adjustments Adjustment of redeemable noncontrolling interest from redemption value to carrying value Temporary Equity, Accretion to Redemption Value Accretion of redeemable noncontrolling interest to redemption value Accretion of redeemable noncontrolling interest to redemption value Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Deficit Issuance of Class A Ordinary Shares in connection with a sale under the ATM, net of $0.2 million of commissions Issuance of Class A ordinary shares Stock Issued During Period, Shares, New Issues Issuance of Class A ordinary shares (in shares) Number of Class A shares issued Number of warrants issued in exchange of shares. Stock Issued During Period, Shares, Issuance Of Warrants In Exchange Of Shares Issuance of Pre-Funded Warrants in exchange for Class A Ordinary Shares (in shares) Issuance of Pre-Funded Warrants in exchange for Class A Ordinary Shares Value of warrants issued in exchange of shares. Stock Issued During Period, Values, Issuance Of Warrants In Exchange Of Shares Issuance of Pre-Funded Warrants in exchange for Class A Ordinary Shares Stock Redeemed or Called During Period, Value Issuance of Pre-Funded Warrants Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Issuance of Class A Ordinary Shares for stock option exercises and restricted stock units, net of shares withheld for taxes Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Issuance of Class A Ordinary Shares for stock option exercises and restricted stock units, net of shares withheld for taxes (in Shares) Restricted Stock, Value, Shares Issued Net of Tax Withholdings Issuance of Class A Ordinary Shares for restricted stock units, net of shares withheld for taxes Restricted Stock, Shares Issued Net of Shares for Tax Withholdings Issuance of Class A Ordinary Shares for restricted stock units, net of shares withheld for taxes (in shares) APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Share-based compensation Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsidiary, Sale of Stock [Line Items] The amount of transaction costs on stock issued. Stock Issued, Transaction Costs Issuance of shares, Transaction costs Condensed Consolidated Statements of Cash Flows Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss before redeemable noncontrolling interest to net cash used in operating activities Share-Based Payment Arrangement, Noncash Expense Share-based compensation expense Depreciation, Depletion and Amortization Depreciation and amortization Gain (Loss), Foreign Currency Transaction, before Tax Foreign exchange transaction loss (gain) Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities Payments to Acquire Property, Plant, and Equipment Purchase of property and equipment Payments to Acquire in Process Research and Development Purchase of research and development license Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities Proceeds from Issuance of Common Stock Proceeds from issuance of Ordinary Shares in connection with business combination Proceeds from issuance of ordinary shares upon closing of business combination Proceeds from Stock Options Exercised Proceeds from exercise of stock options Payment, Tax Withholding, Share-Based Payment Arrangement Restricted stock units withheld to pay employee withholding taxes Proceeds from Issuance of Private Placement Proceeds from issuance of Class A Ordinary Shares in connection with April 2024 Private Placement, net of $7.2 million of transaction costs Aggregate purchase price Proceeds from Issuance of Warrants Proceeds from issuance of Pre-Funded Warrants in connection Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Net (decrease) increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash and cash equivalents, ending of period Cash and cash equivalents, beginning of period Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental Disclosure of Non-Cash Investing and Financing Activities Non cash, value of adjustment from redemption value to carrying value of temporary equity during the period. Temporary Equity, Redemption Value To Carrying Value Adjustment, Non-cash Activities Adjustment of redeemable noncontrolling interest from redemption value to carrying value Capital Expenditures Incurred but Not yet Paid Purchase of property and equipment included in accounts payable and accrued expenses Organization and Description of Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Organization and Description of Business Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Fair Value Measurements Fair Value Disclosures [Text Block] Fair Value Measurements Accounts Payable and Accrued Expenses Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accounts Payable and Accrued Expenses License Asset Acquisition [Text Block] License No definition available. Shareholders' Equity The entire disclosure for temporary equity and shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income Temporary Equity Disclosure and Stockholders' Equity Note Disclosure [Text Block] Shareholders' Equity No definition. Warrants The entire disclosure of derivative warrant liabilities. Derivative Warrant Liabilities Disclosure [Text Block] Warrants Share-based Compensation Share-Based Payment Arrangement [Text Block] Share-based Compensation Commitments and Contingencies. Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Redeemable Noncontrolling Interest Redeemable Noncontrolling Interest [Table Text Block] Redeemable Noncontrolling Interest Defined Contribution Plans Defined Contribution Plan [Text Block] Defined Contribution Plans Subsequent Events Subsequent Events [Text Block] Subsequent Events Basis of Accounting, Policy [Policy Text Block] Basis of Presentation and Principles of Consolidation Disclosure of accounting policy for significant accounting policies. Significant of Accounting, Policy [Policy Text Block] Significant Accounting Policies Use of Estimates, Policy [Policy Text Block] Use of Estimates Disclosure of accounting policy for risks and uncertainties. Risks and Uncertainties Policy [Policy Text Block] Risks and Uncertainties Segment Reporting, Policy [Policy Text Block] Segments Disclosure of accounting policy for research and development incentive credits earned as part of R&D Small and Medium Enterprise (SME) and Research and Development Expenditure Credit (RDEC) tax relief programs. Research And Development Incentive Credits [Policy Text Block] R&D Incentive Credits Earnings Per Share, Policy [Policy Text Block] Net Loss Per Share New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Pronouncements Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of potentially dilutive securities not included in calculation of diluted net loss per share because to do so would be anti-dilutive Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Schedule of financial assets and liabilities measured at fair value on a recurring basis Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of accounts payable and accrued expenses The tabular disclosure of shares reserved for issuance. Summary of Shares Reserved For Issuance [Table Text Block] Schedule of shares reserved for issuance Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Plan Name [Axis] Plan Name [Domain] Represents information pertaining to 2023 equity incentive plan. Equity Incentive Plan 2023 [Member] Equity Incentive Plan 2023 Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-based Compensation Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of weighted-average assumptions used to estimate the fair value Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of company's share option activity Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Schedule of restricted share units Nonvested Restricted Stock Shares Activity [Table Text Block] Schedule of restricted share awards Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Schedule of share-based compensation expense The number participants. Number of Participants Number of participants Sale of Stock, Consideration Received on Transaction Aggregate sales price Number of Operating Segments Number of operating segments Nature of Operation, Product Information, Concentration of Risk [Table] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Domain] Other Income [Member] Other Income Product Information [Line Items] Summary of Significant Accounting Policies Number of claims filed under tax relief programs during the year. Number Of Claims Filed Number of claims filed Amount of research and development incentive credit claim made during the period. Research And Development Inventive Credit R&D Credit Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Shares issuable upon exercise of options to purchase Class A Ordinary Shares Represents the information pertaining to Z33 Series Seed Preferred Shares Put Right. Z33 Series Seed Preferred Shares Put Right [Member] Shares issuable upon exercise of Z33 Put Right Restricted Stock Units (RSUs) [Member] Shares issuable upon release of restricted share units Shares issuable upon vesting of restricted share units Restricted Stock [Member] Restricted share awards Warrant [Member] Shares issuable upon exercise of the Warrants to purchase Class A Ordinary Shares Shares issuable upon exercise of pre-funded warrants to purchase Class A Ordinary Shares Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Summary of Significant Accounting Policies Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Total Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1 [Member] Level 1 Asset Class [Axis] Asset Class [Domain] Cash Equivalents [Member] Cash equivalents Measurement Frequency [Axis] Measurement Frequency [Domain] Fair Value, Recurring [Member] Fair value recurring Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Measurements Assets, Fair Value Disclosure Financial assets Amount of transfers of liabilities measured on a recurring basis between Level 1 and Level 2. Fair Value, Liability, Level 1 to Level 2 Transfers, Amount Transfers between level 1 and level 2 Amount of transfers of liabilities measured on a recurring basis between Level 2 and Level 3. Transfers between level 2 and level 3 Transfers level 2 and level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net Transfers into or out of level 3 Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value, Recurring and Nonrecurring [Table] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurements Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Class of Warrant or Right, Outstanding Warrants outstanding Private Placement Warrants outstanding Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development expense. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Research And Development Expense Current Accrued research and development costs Carrying value as of the balance sheet date of obligations incurred through that date and payable for payroll costs, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued 2023 Lilly License Costs Accrued 2023 Lilly License costs Accrued Bonuses, Current Accrued bonus Accounts Payable, Current Accounts payable Accrued Professional Fees, Current Accrued professional fees Other Accrued Liabilities, Current Other accrued expenses Asset Acquisition [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Represents the information pertaining to License agreement with Lilly. License Agreement with Lilly [Member] License agreement with Lilly Asset Acquisition [Axis] Asset Acquisition [Domain] Represents the information pertaining to Stone Peach Properties, LLC. Stone Peach Properties, LLC [Member] Stone Peach Properties, LLC Stone Peach Research and Development Expense [Member] Research and development Statement of Financial Position Location, Balance [Axis] Statement of Financial Position Location, Balance [Domain] Accounts Payable and Accrued Liabilities [Member] Accounts Payable and Accrued Liabilities Statement of Financial Position Location, Activity, Accrual [Axis] Statement of Financial Position Location, Activity, Accrual [Domain] Counterparty Name [Axis] Counterparty Name [Domain] Represents the information pertaining to BAFFX17, Ltd. BAFFX17, Ltd [Member] BAFFX17, Ltd Consolidated Entities [Axis] Consolidated Entities [Domain] Represents the information pertaining to ZB17 LLC. ZB17 LLC [Member] ZB17 LLC Asset Acquisition [Line Items] License Agreements Shareholders' Equity The issued call right to purchase, percentage of fully-diluted equity. Issued Call Right To Purchase, Percentage Of Fully-Diluted Equity Issued call right to purchase, percentage of fully-diluted equity The value of issued call right. Value Of Issued Call Right Value of issued call right The expiry term from the date of regulatory approval milestone. Expiry Term From The Date Of Regulatory Approval Milestone Expiry term from the date of regulatory approval milestone Payments to Acquire Intangible Assets Annual amount of payment The percentage of annual increase in payment. Percentage Of Annual Increase In Payment Percentage of annual increase in payment The amount of one-time milestone payment. One-time Milestone Payment One-time milestone payment The one-time milestone payment on achievement of conditions. One-Time Milestone Payment On Achievement Of Conditions One-time milestone payment on achievement of conditions The minimum value of closing of an issuance of equity for milestone payment. Minimum Value Of Closing Of An Issuance Of Equity For Milestone Payment Minimum value of closing of an issuance of equity for milestone payment The minimum net proceeds from sale of assets for one-time milestone payment. Minimum Net Proceeds From Sale Of Assets For One-Time Milestone Payment Minimum net proceeds from sale of assets for one-time milestone payment The minimum fully diluted shares outstanding for milestone payment. Minimum Fully Diluted Shares Outstanding For Milestone Payment Minimum fully diluted shares outstanding for milestone payment The fully diluted shares exceeded the minimum limit for milestone payment. Fully Diluted Shares Exceeded the Minimum Limit for Milestone Payment Fully diluted shares exceeded the minimum limit for milestone payment Represents the number of development and regulatory milestone payments in asset acquisition. Asset Acquisition, Consideration, Number of Development And Regulatory Milestone Payments Number of development and regulatory milestone payments Number of Commercial, development and regulatory milestone payments Represents the maximum amount of development and regulatory milestone payments based on respective thresholds of net sales of products (developed from the licensed compound) (the "Products") in asset acquisition. Asset Acquisition, Consideration, Maximum Development And Regulatory Milestone Payments Based On Respective Thresholds Of Net Sales Of Products Maximum amount of development and regulatory milestone payments Represents the maximum amount of sales milestone payments based on respective thresholds of net sales of products (developed from the licensed compound) (the "Products") in asset acquisition. Asset Acquisition, Consideration, Maximum Sales Milestone Payments Based On Respective Thresholds Of Net Sales Of Products Maximum amount of sales milestone payments The period for payment of milestone payment. Period for payment of Milestone Payment Period for payment of milestone payment The percentage of royalty fee. Percentage of Royalty Fee Percentage of royalty fee The amount of contingent payments due. Contingent Payment Due Contingent payments due Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Represents the information pertaining to Z33 Series Seed Preferred Shares. Z33 Series Seed Preferred Shares [Member] Shares issuable upon exercise of Z33 Series Seed Preferred Shares Put Right Common Class A [Member] Class A Ordinary shares Option Indexed to Issuer's Equity, Type [Axis] Option Indexed to Issuer's Equity, Type [Domain] Call Option [Member] Call option Put Option [Member] Put option Subsequent Event Type [Axis]. Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Events The number of shares of equity interests issued or issuable to acquire entity. Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable, Number of Shares Number of shares transferred Represents the percentage of right but not the obligation for purchase of issued shares, maximum percentage. Right But Not the Obligation for Purchase of Issued Shares, Maximum Percentage Right but not the obligation for purchase of issued shares, maximum percentage The per share amount of purchase price per share. Purchase Price Per Share Purchase price per share The threshold period from the date of agreement for purchase of issued shares in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Threshold Period From the Date of Agreement for Purchase of Issued Shares Threshold period from the date of agreement for purchase of issued shares Represents the percentage of he right but not the obligation to sell the issued shares, maximum percentage. Right But Not the Obligation to Sell the Issued Shares, Maximum Percentage Right but not the obligation to sell the issued shares, maximum percentage The per share amount of selling price per share. Selling Price Per Share Selling price per share The number of shares issued on exercise of call options. Number of Shares Issued on Exercise of Call Option Number of shares issued on exercise of call options Percentage of obligation for purchase of holdings upon exercise of put right by holder. Obligation For Purchase of Holdings Upon Exercise of Put Right By Holder, Percent Put right percentage Amount of consideration payable for settlement of option contract upon exercise of right by holder. Purchase consideration for Settlement Of Option Contract Consideration payable Number Of Shares Issued Upon Exercise Of Put Option By Holder shares duration Number of shares issued to holder of put option upon exercising his rights to sell. Number Of Shares Issued Upon Exercise Of Put Option By Holder Shares of put option The amount of obligation to pay upon the completion of financing. Amount of Obligation to Pay Upon the Completion of Financing Amount of obligation to pay upon the completion of financing The minimum gross proceeds from financing for obligation to pay. Minimum Gross Proceeds From Financing for Obligation to Pay Minimum gross proceeds from financing for obligation to pay Represents the maximum percentage of payment of annual earned royalty at a marginal royalty rate. Asset Acquisition, Consideration, Maximum Percentage of Payment of Annual Earned Royalty At A Marginal Royalty Rate Maximum annual earned royalty at a marginal royalty rate Represents the member information pertaining to License Agreement and a Series A-1 Subscription and Shareholder's Agreement with Pfizer. License Agreement and a Series A-1 Subscription and Shareholder's Agreement with Pfizer [Member] Agreement with Pfizer Represents the information pertaining to Lonza license agreement. Lonza License Agreement [Member] Lonza milestone payment Represents information pertaining to Wuxi Biologics License. Wuxi Biologics License [Member] Wuxi Biologics License The amount of development milestone recognized as a component of research and development. Amount of Development Milestone Recognized as a Component of Research and Development Development Of research and development The amount of license costs payable. Accrued License Costs Amount of license costs payable Amount of milestone payment to be made annually under the terms of agreement. Annual Milestone Payment, Due And Payable Annual milestone payment, due and payable Number of shares surrendered. Number Of Shares Surrendered Number of shares surrendered Represents the amount of shares surrendered. Value of Shares Surrendered Consideration for shares surrendered Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of warrants exercised Number of warrants exchanged for shares Aggregate amount of shares reserved for future issuance. Capital Shares Reserved for Future Issuance, Amount Aggregate amount of shares reserved Payments of Stock Issuance Costs Transaction costs Shares Issued, Price Per Share Price per share Sale price per share Number of shares issued in lieu of exchange of warrants. Stock Issued During Period, Shares, Exchange Of Warrants Issuance of Class A Ordinary Shares in exchange (in shares) Shares issued in exchange of warrants The price per warrant issued. Price per Warrant Issued Price per warrant Sale price per warrant Proceeds from Issuance or Sale of Equity Proceeds from sale of shares and warrants Collaborative Arrangement and Arrangement Other than Collaborative [Table] Represents information pertaining to 2023 equity incentive plan and 2023 employee stock purchase plan. Equity Incentive Plan 2023 And Employee Stock Purchase Plan 2023 [Member] Shares available for grant under Equity Incentive Plan and ESPP Shares available for grant under 2023 Equity Incentive Plan and ESPP Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Shareholders' Equity Common Stock, Capital Shares Reserved for Future Issuance Shares reserved for issuance Disclosure of derivative warrant liabilities. Derivative Warrant Liabilities [Table] Private Placement [Member] Private placement April 2023 Represents the information pertaining to warrants issued 23,884,348 exercise price 0.001. Warrants Issued 23,884,348 Exercise Price 0.001 [Member] Warrant issued 23,884,348 exercise price 0.001 Represents information pertaining to redeemable warrant (public warrant) that entitles the holder to purchase shares of common stock subject to adjustment. Public Warrants [Member] Public warrants Represents the information pertaining to subscription agreements with PIPE Investors. Subscription agreements with PIPE Investor [Member] Subscription Agreement Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum [Member] Maximum Minimum [Member] Minimum Line items represents the information pertaining to derivative warrant liabilities. DERIVATIVE WARRANT LIABILITIES [Line Items] Warrants Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Number of Class A ordinary shares upon exercise of each warrant Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price of warrants The threshold percentage of outstanding shares owned. Threshold Percentage Of Outstanding Shares Owned Percentage of shares outstanding immediately prior to or after giving effect to exercise of share exchange Threshold percentage of outstanding shares owned beyond which increase is not possible. Threshold Percentage of Outstanding Shares Owned, Holder's Election Upon Written Notice Percentage of shares outstanding immediately after giving effect to exercise of share exchange The period of notice in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Class of Warrant or Right, Threshold Notice Period Notice period ( in days) The information pertaining to side Of Equity Incentive Plan. Outside Of Equity Incentive Plan [Member] Outside of equity plan Represents the information pertaining to employee stock purchase plan. Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Share based payment award, option to vest (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Expiration term (in years) Expected life Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Share based compensation arrangement Share options issued Represents the percentage of aggregate number of ordinary Shares outstanding. Percentage of Aggregate Number of Ordinary Shares Outstanding Percentage of ordinary shares outstanding Percentage of Discount on common shares, or any unamortized balance thereof, shown separately as a deduction from the applicable account(s) as circumstances require. Common Stock, Discount on Shares, Percentage Percentage of discount for eligible employees The percentage of annual automatic increase in the aggregate number of common shares reserved for future issuance. Common Stock, Capital Shares Reserved for Future Issuance, Automatic Increase Percentage Shares reserved for future issuances, increased percentage The annual automatic increase in the aggregate number of common shares reserved for future issuance during the reporting period. Common Stock, Capital Shares Reserved for Future Issuance, Automatic Increase Number Shares reserved for future issuances, increased shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Number of options granted Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Maximum number of shares authorized Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] Weighted-average assumptions used to estimate the fair value Share price for the exchange of the underlying asset relating to the share-based payment award. Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Share Price Share price Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend yield Title and Position [Axis] Title and Position [Domain] Represent information pertaining to directors, executives, and employees. Directors Executives And Employees [Member] Directors Executives And Employees Represents the member information pertaining to Non Market-Based Performance Share Options. Non Market Based Performance Share Options [Member] Non market based PSO Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Ending balance Beginning balance Number of options outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price (per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Ending balance Beginning balance Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted Exercise price of shares granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Exercised Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Options vested and exercisable no definition. Share-Based Compensation Arrangement by Share-Based Payment Award, Weighted Average Remaining Contractual Life [Abstract] Weighted Average Remaining Contractual Life (Years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Options outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Options vested and exercisable No definition. Share-Based Compensation Arrangement by Share-Based Payment Award, Aggregate Intrinsic Value [Abstract] Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Options outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Additional Information Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Service period Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Unrecognized share-based compensation expense Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average grant date fair value Represents the member information pertaining to Market-Based Performance Share Options. Market-Based Performance Share Options [Member] Market-Based Share Options Represents the number of days based on which the weighted average trading price ("VWAP") is determined. Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Vesting, Number of Days Based on Which Volume Weighted Average Trading Price is Determined Period of volume weighted average trading price ("VWAP") Represents the minimum price per share for vesting awards. Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Minimum Price per Share For Vesting of Award Minimum price per share for vesting awards Represents the threshold period of vesting from grant date. Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Threshold Period From Grant Date for Vesting of Awards Threshold period from grant date for vesting awards Share-Based Payment Arrangement, Expense Share-based compensation expense Expense recognized Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Number of RSUs Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Ending balance Beginning balance The number of equity-based payment instruments, excluding stock (or unit) options, that were vested and issued by the entity during the reporting period. Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Vested And Issued In Period Vested and issued Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Ending balance Beginning balance The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right and also issued by the entity during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Vested And Issued In Period, Weighted Average Grant Date Fair Value Vested and issued Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Vested Director [Member] Director Chief Financial Officer [Member] Chief Financial Officer Scenario [Axis] Scenario [Domain] Represents information pertaining to scenario indicating amendment of option agreements. Amendment of Option Agreements [Member] Amendment of option agreements Represents information pertaining to scenario indicating extension of post termination exercise period. Extension Of Post-Termination Exercise Period [Member] Post-termination exercise period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Share based payment award, options, vested, number of shares General and Administrative Expense [Member] General and administrative Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Share-based compensation expense expected to be recognized over a weighted average period Redeemable Noncontrolling Interest [Table] Represents information pertaining to Z33 Bio, Inc. Z33 Bio, Inc. [Member] Z33 Redeemable Noncontrolling Interest [Line Items] Redeemable Noncontrolling Interest The percentage of the call options exercised. Percentage of the Call Options Exercised Percentage of the call options exercised The number of shares in exchange for exercise of Put Right. Number of Shares On Exercise of Put Right Number of shares in exchange for exercise of put Right Defined Contribution Plan [Table] Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Domain] Domestic Plan [Member] Domestic Plan UNITED STATES US Foreign Plan [Member] Foreign Plan UNITED KINGDOM UK Defined Contribution Plan Disclosure [Line Items] Defined Contribution Plans Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Matching contribution percent Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage Employers matching contribution, annual vesting percentage Defined Contribution Plan, Cost Defined contribution plan expenses Subsequent Event [Table] Subsequent Event [Line Items] Subsequent Events Represents the number of warrants exercised or redeemed. Number Of Warrants Exercised Or Redeemed Number of warrants exercised or redeemed